Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
about
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic reviewAutoimmune thrombocytopenia.Management of patients with refractory immune thrombocytopenic purpura.Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura.Investigation of whether the acute hemolysis associated with Rh(o)(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model.Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.Anti-RhD immunoglobulin in the treatment of immune thrombocytopeniaLong-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomyPathophysiology and therapeutic options in primary immune thrombocytopenia.Current treatment options for primary immune thrombocytopenia.Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopeniaEltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsia.Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature review.Emerging drugs for immune thrombocytopenia (ITP).Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients.A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonistsLaparoscopic splenectomy: present status and future perspective.Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis.
P2860
Q26826853-B03927FB-0F52-4AE0-864A-DB48EE07DDCAQ33367861-98E73850-D2D0-4A2B-90EB-3A54DA40AD78Q33372113-A8D9AC68-7142-4470-BD75-A47DEBE6AB9BQ33375988-BAF6CBCD-1651-47DC-AA9A-573587B97BFAQ33383303-35B489EF-A5C3-418D-AB7A-C08F27D727BCQ33385549-A49F01E7-B3A0-48A0-9429-58A7399B1F23Q33385974-ABC6F1EA-807D-49D4-92A6-9EB93E58C60CQ33393057-C3264AD2-DAB2-48CC-A7A3-6AA09F8C788AQ33393732-04FD5605-42D7-49CF-99D5-CB1F82800C7EQ33394149-368FD96F-14BD-4AF7-92FC-5CBBE661F3E8Q33400722-A50CB197-C24E-4946-A6BB-6CEBB8B300E6Q33406838-C6BC038B-51D1-449D-9A3D-A5D22CBA4E37Q33425102-B28E3743-D363-4D51-9B04-ED41C6DC6240Q33433705-376D97B4-C313-4A70-8377-BFD4FA818D34Q33439789-091DA064-E44F-4213-AF30-2F477D3B1081Q34462497-71975553-64B4-43A9-999C-1CC650899B80Q35683792-22027AE2-47C6-415D-BA43-8F6143F6EC14Q36344086-3CF1F547-C5B0-4F60-AC2D-AD67E7DBDFB9Q47876652-180F4197-BA86-4B6E-B78F-7534289AC3A4
P2860
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Initial management of immune t ...... tent anti-D with routine care.
@ast
Initial management of immune t ...... tent anti-D with routine care.
@en
type
label
Initial management of immune t ...... tent anti-D with routine care.
@ast
Initial management of immune t ...... tent anti-D with routine care.
@en
prefLabel
Initial management of immune t ...... tent anti-D with routine care.
@ast
Initial management of immune t ...... tent anti-D with routine care.
@en
P2093
P356
P1476
Initial management of immune t ...... tent anti-D with routine care.
@en
P2093
Brenda L Towell
Dennis Moore
Everardo Cobos
Gary E Raskob
James N George
Panpit Klug
Roger M Lyons
Troy H Guthrie
P304
P356
10.1002/AJH.10424
P577
2003-11-01T00:00:00Z